By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856



Company News
Omeros (OMER) Announces Pricing Of Public Offering Of Common Stock 8/15/2017 7:48:56 AM
Omeros (OMER) Data Show Continued Improvement In Patients With IgA Nephropathy Treated With OMS721 8/15/2017 6:56:57 AM
Omeros (OMER) Announces Public Offering Of Common Stock 8/15/2017 6:31:42 AM
Omeros (OMER) To Present At The 2017 Wedbush Pacgrow Healthcare Conference 8/10/2017 10:17:15 AM
Omeros (OMER) Reports Second Quarter 2017 Financial Results 8/9/2017 7:32:31 AM
FDA Grants Orphan Drug Designation To Omeros (OMER)’ OMS721 For Treatment Of IgA Nephropathy 8/4/2017 11:34:39 AM
Omeros (OMER) To Announce Second Quarter 2017 Financial Results On August 8, 2017 8/2/2017 8:08:56 AM
Omeros (OMER): Next Big Thing In Biotech 7/5/2017 6:36:15 AM
Omeros (OMER) Releases Statement In Response To Recent False Report 6/29/2017 7:10:47 AM
Omeros (OMER) Pursuing Legal Action Against Short Seller for Report That Caused Stock to Tank This Week 6/29/2017 6:01:06 AM